This Wix.com Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
Analysts downgraded Wix, DraftKings, Carlyle, Peabody Energy and Trex, cutting ratings and/or price targets.
Stocks · News reference
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $90
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Globus Medical to Participate in Jefferies Global Healthcare Conference
Globus Medical, Inc. announced it is scheduled to participate in the upcoming Jefferies Global Healthcare Conference in London.
This Zillow Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Wall Street analysts downgraded DraftKings, PDD Holdings, TransUnion, Molson Coors and Zillow, adjusting price targets and ratings.
GMED Q3 Earnings Call Highlights Guidance Cut and 2027 Reset
Globus Medical lowered its 2026 revenue guidance to $3.09B from $3.18B-$3.22B due to delayed spine product launches, slower sales rep productivity, and a 25.7% drop in Nevro sales. The company maintained non-GAAP earnings guidance and is targeting 2027 growth from new products including SCRIPT, EIQ, and HFX Elite, supported by cost discipline.
Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $100
Needham Adjusts Price Target on Globus Medical
Needham has lowered its price target for Globus Medical while maintaining a Buy rating on the stock.